Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir with Daclatasvir or Simeprevir in HCV GT1
NCT02624063Phase 4Completed
- Sponsor
- Federal University of São Paulo
- Start
- Dec 2015
- Primary completion
- Mar 2017
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir, daclatasvir, simeprevir in hepatitis C (HCV), sponsored by Federal University of São Paulo. Started Dec 2015; status: completed.
02
Drugs
sofosbuvirdaclatasvirsimeprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02624063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624063.